Creating  ||| S:0 E:9 ||| VBG
the  ||| S:9 E:13 ||| DT
animated  ||| S:13 E:22 ||| JJ
intensive  ||| S:22 E:32 ||| JJ
care  ||| S:32 E:37 ||| NN
unit  ||| S:37 E:42 ||| NN
Critical  ||| S:42 E:51 ||| JJ
care  ||| S:51 E:56 ||| NN
medicine  ||| S:56 E:65 ||| NN
has  ||| S:65 E:69 ||| VBZ
matured  ||| S:69 E:77 ||| VBN
greatly  ||| S:77 E:85 ||| RB
as  ||| S:85 E:88 ||| IN
a  ||| S:88 E:90 ||| DT
field  ||| S:90 E:96 ||| NN
in  ||| S:96 E:99 ||| IN
the  ||| S:99 E:103 ||| DT
past  ||| S:103 E:108 ||| JJ
decade ||| S:108 E:114 ||| NN
.  ||| S:114 E:116 ||| .
Much  ||| S:116 E:121 ||| RB
has  ||| S:121 E:125 ||| VBZ
been  ||| S:125 E:130 ||| VBN
learned  ||| S:130 E:138 ||| VBN
concerning  ||| S:138 E:149 ||| VBG
the  ||| S:149 E:153 ||| DT
institution  ||| S:153 E:165 ||| NN
of  ||| S:165 E:168 ||| IN
life  ||| S:168 E:173 ||| NN
support  ||| S:173 E:181 ||| NN
therapies  ||| S:181 E:191 ||| NNS
to  ||| S:191 E:194 ||| TO
sustain  ||| S:194 E:202 ||| VB
patients  ||| S:202 E:211 ||| NNS
with  ||| S:211 E:216 ||| IN
diverse  ||| S:216 E:224 ||| JJ
and  ||| S:224 E:228 ||| CC
multiple  ||| S:228 E:237 ||| JJ
organ  ||| S:237 E:243 ||| NN
failures ||| S:243 E:251 ||| NNS
,  ||| S:251 E:253 ||| ,
thus  ||| S:253 E:258 ||| RB
providing  ||| S:258 E:268 ||| VBG
patients  ||| S:268 E:277 ||| NNS
with  ||| S:277 E:282 ||| IN
a  ||| S:282 E:284 ||| DT
window  ||| S:284 E:291 ||| NN
of  ||| S:291 E:294 ||| IN
opportunity  ||| S:294 E:306 ||| NN
to  ||| S:306 E:309 ||| TO
recover  ||| S:309 E:317 ||| VB
from  ||| S:317 E:322 ||| IN
potentially  ||| S:322 E:334 ||| RB
life-ending  ||| S:334 E:346 ||| JJ
insults ||| S:346 E:353 ||| NN
.  ||| S:353 E:355 ||| .
The  ||| S:355 E:359 ||| DT
management  ||| S:359 E:370 ||| NN
of  ||| S:370 E:373 ||| IN
critically  ||| S:373 E:384 ||| RB
ill  ||| S:384 E:388 ||| JJ
patients  ||| S:388 E:397 ||| NNS
has  ||| S:397 E:401 ||| VBZ
increasingly  ||| S:401 E:414 ||| RB
involved  ||| S:414 E:423 ||| VBN
creation  ||| S:423 E:432 ||| NN
of  ||| S:432 E:435 ||| IN
a  ||| S:435 E:437 ||| DT
highly  ||| S:437 E:444 ||| RB
controlled  ||| S:444 E:455 ||| VBN
environment  ||| S:455 E:467 ||| NN
by  ||| S:467 E:470 ||| IN
care  ||| S:470 E:475 ||| NN
providers ||| S:475 E:484 ||| NNS
,  ||| S:484 E:486 ||| ,
with  ||| S:486 E:491 ||| IN
patients  ||| S:491 E:500 ||| NNS
immobilized ||| S:500 E:511 ||| NN
,  ||| S:511 E:513 ||| ,
tethered  ||| S:513 E:522 ||| VBN
to  ||| S:522 E:525 ||| TO
devices ||| S:525 E:532 ||| NNS
,  ||| S:532 E:534 ||| ,
and  ||| S:534 E:538 ||| CC
receiving  ||| S:538 E:548 ||| VBG
multiple  ||| S:548 E:557 ||| JJ
drugs  ||| S:557 E:563 ||| NNS
to  ||| S:563 E:566 ||| TO
facilitate  ||| S:566 E:577 ||| VB
the  ||| S:577 E:581 ||| DT
entire  ||| S:581 E:588 ||| JJ
process ||| S:588 E:595 ||| NN
.  ||| S:595 E:597 ||| .
Although  ||| S:597 E:606 ||| IN
it  ||| S:606 E:609 ||| PRP
has  ||| S:609 E:613 ||| VBZ
been  ||| S:613 E:618 ||| VBN
assumed  ||| S:618 E:626 ||| VBN
that  ||| S:626 E:631 ||| IN
such  ||| S:631 E:636 ||| JJ
control  ||| S:636 E:644 ||| NN
of  ||| S:644 E:647 ||| IN
the  ||| S:647 E:651 ||| DT
patient  ||| S:651 E:659 ||| NN
has  ||| S:659 E:663 ||| VBZ
been  ||| S:663 E:668 ||| VBN
necessary  ||| S:668 E:678 ||| JJ
to  ||| S:678 E:681 ||| TO
implement  ||| S:681 E:691 ||| VB
essential  ||| S:691 E:701 ||| JJ
therapies  ||| S:701 E:711 ||| NNS
and  ||| S:711 E:715 ||| CC
to  ||| S:715 E:718 ||| TO
tailor  ||| S:718 E:725 ||| VB
life  ||| S:725 E:730 ||| NN
support  ||| S:730 E:738 ||| NN
systems  ||| S:738 E:746 ||| NNS
such  ||| S:746 E:751 ||| JJ
as  ||| S:751 E:754 ||| IN
mechanical  ||| S:754 E:765 ||| JJ
ventilation ||| S:765 E:776 ||| NN
,  ||| S:776 E:778 ||| ,
this  ||| S:778 E:783 ||| DT
assumption  ||| S:783 E:794 ||| NN
may  ||| S:794 E:798 ||| MD
be  ||| S:798 E:801 ||| VB
unfounded  ||| S:801 E:811 ||| JJ
or  ||| S:811 E:814 ||| CC
at  ||| S:814 E:817 ||| IN
least  ||| S:817 E:823 ||| JJS
overplayed ||| S:823 E:833 ||| NN
,  ||| S:833 E:835 ||| ,
as  ||| S:835 E:838 ||| IN
knowledge  ||| S:838 E:848 ||| NN
of  ||| S:848 E:851 ||| IN
the  ||| S:851 E:855 ||| DT
adverse  ||| S:855 E:863 ||| JJ
effects  ||| S:863 E:871 ||| NNS
of  ||| S:871 E:874 ||| IN
this  ||| S:874 E:879 ||| DT
approach  ||| S:879 E:888 ||| NN
have  ||| S:888 E:893 ||| VBP
been  ||| S:893 E:898 ||| VBN
identified  ||| S:898 E:909 ||| VBN
and  ||| S:909 E:913 ||| CC
quantified ||| S:913 E:923 ||| NN
.  ||| S:923 E:925 ||| .
Extant  ||| S:925 E:932 ||| JJ
information ||| S:932 E:943 ||| NN
,  ||| S:943 E:945 ||| ,
based  ||| S:945 E:951 ||| VBN
on  ||| S:951 E:954 ||| IN
observational  ||| S:954 E:968 ||| JJ
studies  ||| S:968 E:976 ||| NNS
and  ||| S:976 E:980 ||| CC
a  ||| S:980 E:982 ||| DT
few  ||| S:982 E:986 ||| JJ
interventional  ||| S:986 E:1001 ||| JJ
trials ||| S:1001 E:1007 ||| NNS
,  ||| S:1007 E:1009 ||| ,
would  ||| S:1009 E:1015 ||| MD
suggest  ||| S:1015 E:1023 ||| VB
a  ||| S:1023 E:1025 ||| DT
radically  ||| S:1025 E:1035 ||| JJ
different  ||| S:1035 E:1045 ||| JJ
approach  ||| S:1045 E:1054 ||| NN
to  ||| S:1054 E:1057 ||| TO
care  ||| S:1057 E:1062 ||| NN
is  ||| S:1062 E:1065 ||| VBZ
warranted ||| S:1065 E:1074 ||| VBN
,  ||| S:1074 E:1076 ||| ,
even  ||| S:1076 E:1081 ||| RB
given  ||| S:1081 E:1087 ||| VBN
the  ||| S:1087 E:1091 ||| DT
difficulties  ||| S:1091 E:1104 ||| NNS
in  ||| S:1104 E:1107 ||| IN
reversing  ||| S:1107 E:1117 ||| VBG
the  ||| S:1117 E:1121 ||| DT
current  ||| S:1121 E:1129 ||| JJ
culture  ||| S:1129 E:1137 ||| NN
of  ||| S:1137 E:1140 ||| IN
critical  ||| S:1140 E:1149 ||| JJ
care  ||| S:1149 E:1154 ||| NN
management ||| S:1154 E:1164 ||| NN
.  ||| S:1164 E:1166 ||| .
Specifically ||| S:1166 E:1178 ||| RB
,  ||| S:1178 E:1180 ||| ,
methods  ||| S:1180 E:1188 ||| NNS
to  ||| S:1188 E:1191 ||| TO
avoid  ||| S:1191 E:1197 ||| VB
entirely ||| S:1197 E:1205 ||| RB
,  ||| S:1205 E:1207 ||| ,
or  ||| S:1207 E:1210 ||| CC
minimize ||| S:1210 E:1218 ||| VB
,  ||| S:1218 E:1220 ||| ,
neuromuscular  ||| S:1220 E:1234 ||| JJ
blockade  ||| S:1234 E:1243 ||| NN
and  ||| S:1243 E:1247 ||| CC
sedation  ||| S:1247 E:1256 ||| NNS
are  ||| S:1256 E:1260 ||| VBP
supported  ||| S:1260 E:1270 ||| VBN
by  ||| S:1270 E:1273 ||| IN
recent  ||| S:1273 E:1280 ||| JJ
literature ||| S:1280 E:1290 ||| NN
.  ||| S:1290 E:1292 ||| .
These  ||| S:1292 E:1298 ||| DT
methods  ||| S:1298 E:1306 ||| NNS
include  ||| S:1306 E:1314 ||| VBP
the  ||| S:1314 E:1318 ||| DT
use  ||| S:1318 E:1322 ||| NN
of  ||| S:1322 E:1325 ||| IN
noninvasive  ||| S:1325 E:1337 ||| JJ
ventilation  ||| S:1337 E:1349 ||| NN
in  ||| S:1349 E:1352 ||| IN
appropriately  ||| S:1352 E:1366 ||| RB
selected  ||| S:1366 E:1375 ||| VBN
patients ||| S:1375 E:1383 ||| NNS
,  ||| S:1383 E:1385 ||| ,
the  ||| S:1385 E:1389 ||| DT
development  ||| S:1389 E:1401 ||| NN
of  ||| S:1401 E:1404 ||| IN
mechanical  ||| S:1404 E:1415 ||| JJ
ventilators  ||| S:1415 E:1427 ||| NN
more  ||| S:1427 E:1432 ||| RBR
synchronous  ||| S:1432 E:1444 ||| JJ
with  ||| S:1444 E:1449 ||| IN
patient  ||| S:1449 E:1457 ||| JJ
efforts  ||| S:1457 E:1465 ||| NNS
and  ||| S:1465 E:1469 ||| CC
needs ||| S:1469 E:1474 ||| NNS
,  ||| S:1474 E:1476 ||| ,
and  ||| S:1476 E:1480 ||| CC
the  ||| S:1480 E:1484 ||| DT
use  ||| S:1484 E:1488 ||| NN
of  ||| S:1488 E:1491 ||| IN
sedation  ||| S:1491 E:1500 ||| JJ
strategies  ||| S:1500 E:1511 ||| NNS
to  ||| S:1511 E:1514 ||| TO
avoid  ||| S:1514 E:1520 ||| VB
drug  ||| S:1520 E:1525 ||| NN
accumulations  ||| S:1525 E:1539 ||| NN
with  ||| S:1539 E:1544 ||| IN
protracted  ||| S:1544 E:1555 ||| JJ
effects ||| S:1555 E:1562 ||| NNS
.  ||| S:1562 E:1564 ||| .
These  ||| S:1564 E:1570 ||| DT
methods ||| S:1570 E:1577 ||| NNS
,  ||| S:1577 E:1579 ||| ,
in  ||| S:1579 E:1582 ||| IN
turn ||| S:1582 E:1586 ||| NN
,  ||| S:1586 E:1588 ||| ,
afford  ||| S:1588 E:1595 ||| VB
opportunities  ||| S:1595 E:1609 ||| NNS
to  ||| S:1609 E:1612 ||| TO
avoid  ||| S:1612 E:1618 ||| VB
extreme  ||| S:1618 E:1626 ||| JJ
immobilization  ||| S:1626 E:1641 ||| NN
and  ||| S:1641 E:1645 ||| CC
institute  ||| S:1645 E:1655 ||| NN
physiotherapy  ||| S:1655 E:1669 ||| NN
earlier  ||| S:1669 E:1677 ||| RBR
than  ||| S:1677 E:1682 ||| IN
previously  ||| S:1682 E:1693 ||| RB
had  ||| S:1693 E:1697 ||| VBD
been  ||| S:1697 E:1702 ||| VBN
thought  ||| S:1702 E:1710 ||| VBN
possible ||| S:1710 E:1718 ||| JJ
.  ||| S:1718 E:1720 ||| .
In  ||| S:1720 E:1723 ||| IN
addition  ||| S:1723 E:1732 ||| NN
to  ||| S:1732 E:1735 ||| TO
the  ||| S:1735 E:1739 ||| DT
neuropsychiatric  ||| S:1739 E:1756 ||| NN
and  ||| S:1756 E:1760 ||| CC
neuromuscular  ||| S:1760 E:1774 ||| JJ
benefits  ||| S:1774 E:1783 ||| NNS
that  ||| S:1783 E:1788 ||| WDT
could  ||| S:1788 E:1794 ||| MD
derive  ||| S:1794 E:1801 ||| VB
from  ||| S:1801 E:1806 ||| IN
minimizing  ||| S:1806 E:1817 ||| VBG
opiate  ||| S:1817 E:1824 ||| JJ
administration  ||| S:1824 E:1839 ||| NN
in  ||| S:1839 E:1842 ||| IN
critically  ||| S:1842 E:1853 ||| RB
ill  ||| S:1853 E:1857 ||| JJ
patients ||| S:1857 E:1865 ||| NNS
,  ||| S:1865 E:1867 ||| ,
gut  ||| S:1867 E:1871 ||| NN
hypomotility  ||| S:1871 E:1884 ||| NNS
could  ||| S:1884 E:1890 ||| MD
be  ||| S:1890 E:1893 ||| VB
avoided ||| S:1893 E:1900 ||| VBN
.  ||| S:1900 E:1902 ||| .
This ||| S:1902 E:1906 ||| DT
,  ||| S:1906 E:1908 ||| ,
in  ||| S:1908 E:1911 ||| IN
turn ||| S:1911 E:1915 ||| NN
,  ||| S:1915 E:1917 ||| ,
could  ||| S:1917 E:1923 ||| MD
facilitate  ||| S:1923 E:1934 ||| VB
earlier  ||| S:1934 E:1942 ||| RBR
and  ||| S:1942 E:1946 ||| CC
more  ||| S:1946 E:1951 ||| RBR
complete  ||| S:1951 E:1960 ||| JJ
enteral  ||| S:1960 E:1968 ||| JJ
nutrition ||| S:1968 E:1977 ||| NN
.  ||| S:1977 E:1979 ||| .
Even  ||| S:1979 E:1984 ||| RB
when  ||| S:1984 E:1989 ||| WRB
opioids  ||| S:1989 E:1997 ||| NNS
have  ||| S:1997 E:2002 ||| VBP
to  ||| S:2002 E:2005 ||| TO
be  ||| S:2005 E:2008 ||| VB
administered  ||| S:2008 E:2021 ||| VBN
in  ||| S:2021 E:2024 ||| IN
generous  ||| S:2024 E:2033 ||| JJ
amounts  ||| S:2033 E:2041 ||| NNS
for  ||| S:2041 E:2045 ||| IN
control  ||| S:2045 E:2053 ||| NN
of  ||| S:2053 E:2056 ||| IN
pain  ||| S:2056 E:2061 ||| NN
that  ||| S:2061 E:2066 ||| WDT
may  ||| S:2066 E:2070 ||| MD
accompany  ||| S:2070 E:2080 ||| VB
critical  ||| S:2080 E:2089 ||| JJ
illness ||| S:2089 E:2096 ||| NN
,  ||| S:2096 E:2098 ||| ,
it  ||| S:2098 E:2101 ||| PRP
is  ||| S:2101 E:2104 ||| VBZ
now  ||| S:2104 E:2108 ||| RB
possible  ||| S:2108 E:2117 ||| JJ
to  ||| S:2117 E:2120 ||| TO
block  ||| S:2120 E:2126 ||| VB
the  ||| S:2126 E:2130 ||| DT
peripheral  ||| S:2130 E:2141 ||| JJ
actions  ||| S:2141 E:2149 ||| NNS
of  ||| S:2149 E:2152 ||| IN
these  ||| S:2152 E:2158 ||| DT
medications  ||| S:2158 E:2170 ||| NN
with  ||| S:2170 E:2175 ||| IN
the  ||| S:2175 E:2179 ||| DT
μ-receptor  ||| S:2179 E:2190 ||| JJ
antagonist  ||| S:2190 E:2201 ||| JJ
methylnaltrexone ||| S:2201 E:2217 ||| NN
.  ||| S:2217 E:2219 ||| .
Other  ||| S:2219 E:2225 ||| JJ
new  ||| S:2225 E:2229 ||| JJ
drugs  ||| S:2229 E:2235 ||| NNS
being  ||| S:2235 E:2241 ||| VBG
introduced  ||| S:2241 E:2252 ||| VBN
into  ||| S:2252 E:2257 ||| IN
the  ||| S:2257 E:2261 ||| DT
critical  ||| S:2261 E:2270 ||| JJ
care  ||| S:2270 E:2275 ||| NN
unit  ||| S:2275 E:2280 ||| NN
such  ||| S:2280 E:2285 ||| JJ
as  ||| S:2285 E:2288 ||| IN
dexmedetomidine  ||| S:2288 E:2304 ||| NNS
may  ||| S:2304 E:2308 ||| MD
also  ||| S:2308 E:2313 ||| RB
provide  ||| S:2313 E:2321 ||| VB
a  ||| S:2321 E:2323 ||| DT
greater  ||| S:2323 E:2331 ||| JJR
ability  ||| S:2331 E:2339 ||| NN
to  ||| S:2339 E:2342 ||| TO
achieve  ||| S:2342 E:2350 ||| VB
analgesia  ||| S:2350 E:2360 ||| NNS
and  ||| S:2360 E:2364 ||| CC
anxiolysis  ||| S:2364 E:2375 ||| NN
without  ||| S:2375 E:2383 ||| IN
some  ||| S:2383 E:2388 ||| DT
of  ||| S:2388 E:2391 ||| IN
the  ||| S:2391 E:2395 ||| DT
adverse  ||| S:2395 E:2403 ||| JJ
concomitant  ||| S:2403 E:2415 ||| JJ
effects  ||| S:2415 E:2423 ||| NNS
seen  ||| S:2423 E:2428 ||| VBN
with  ||| S:2428 E:2433 ||| IN
more  ||| S:2433 E:2438 ||| RBR
traditional  ||| S:2438 E:2450 ||| JJ
drug  ||| S:2450 E:2455 ||| NN
regimens ||| S:2455 E:2463 ||| NN
.  ||| S:2463 E:2465 ||| .
The  ||| S:2465 E:2469 ||| DT
ultimate  ||| S:2469 E:2478 ||| JJ
goal  ||| S:2478 E:2483 ||| NN
of  ||| S:2483 E:2486 ||| IN
this  ||| S:2486 E:2491 ||| DT
multipronged  ||| S:2491 E:2504 ||| JJ
program  ||| S:2504 E:2512 ||| NN
to  ||| S:2512 E:2515 ||| TO
facilitate  ||| S:2515 E:2526 ||| VB
the  ||| S:2526 E:2530 ||| DT
maintenance  ||| S:2530 E:2542 ||| NN
of  ||| S:2542 E:2545 ||| IN
patients  ||| S:2545 E:2554 ||| NNS
who  ||| S:2554 E:2558 ||| WP
are  ||| S:2558 E:2562 ||| VBP
more  ||| S:2562 E:2567 ||| RBR
interactive  ||| S:2567 E:2579 ||| JJ
with  ||| S:2579 E:2584 ||| IN
their  ||| S:2584 E:2590 ||| PRP$
care  ||| S:2590 E:2595 ||| NN
providers ||| S:2595 E:2604 ||| NNS
,  ||| S:2604 E:2606 ||| ,
and  ||| S:2606 E:2610 ||| CC
the  ||| S:2610 E:2614 ||| DT
life  ||| S:2614 E:2619 ||| NN
support  ||| S:2619 E:2627 ||| NN
provided  ||| S:2627 E:2636 ||| VBN
in  ||| S:2636 E:2639 ||| IN
the  ||| S:2639 E:2643 ||| DT
intensive  ||| S:2643 E:2653 ||| JJ
care  ||| S:2653 E:2658 ||| NN
unit  ||| S:2658 E:2663 ||| NN
would  ||| S:2663 E:2669 ||| MD
be  ||| S:2669 E:2672 ||| VB
to  ||| S:2672 E:2675 ||| TO
speed  ||| S:2675 E:2681 ||| VB
the  ||| S:2681 E:2685 ||| DT
pace  ||| S:2685 E:2690 ||| NN
of  ||| S:2690 E:2693 ||| IN
recovery  ||| S:2693 E:2702 ||| NN
and  ||| S:2702 E:2706 ||| CC
to  ||| S:2706 E:2709 ||| TO
diminish  ||| S:2709 E:2718 ||| VB
the  ||| S:2718 E:2722 ||| DT
need  ||| S:2722 E:2727 ||| NN
for  ||| S:2727 E:2731 ||| IN
the  ||| S:2731 E:2735 ||| DT
protracted  ||| S:2735 E:2746 ||| JJ
rehabilitation  ||| S:2746 E:2761 ||| NN
that  ||| S:2761 E:2766 ||| WDT
often  ||| S:2766 E:2772 ||| RB
follows  ||| S:2772 E:2780 ||| VBZ
survival  ||| S:2780 E:2789 ||| NN
from  ||| S:2789 E:2794 ||| IN
critical  ||| S:2794 E:2803 ||| JJ
illness ||| S:2803 E:2810 ||| NN
.  ||| S:2810 E:2812 ||| .
